Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wella Supervisory Board

This article was originally published in The Rose Sheet

Executive Summary

Four new members named to Wella's Supervisory Board, firm announces Sept. 18. Martin Nuchtern, Rainer Henes, Dieter Judith and Gerhard Wirth are assuming their roles following the departure of four members who had resigned in connection with the acquisition of the majority voting rights in Wella AG by Procter & Gamble. Supervisory Board also elects Wirth as chairman. In response to the appointments, a group of Wella preference shareholders advised by investment bank Close Brothers released a statement expressing dissatisfaction that three of the appointees are affiliated with P&G, maintaining the appointments should be independent. The shareholder group contends the move is "inconsistent" with the statement of independence made by the Wella management board Sept. 2, the day P&G closed the acquisition (1"The Rose Sheet" Sept. 8, 2003, p. 4)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011534

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel